Segall Bryant & Hamill Buys New $1.02M Stake in Biogen
Segall Bryant & Hamill LLC bought 5,379 Biogen shares worth about $1.02 million, adding to recent holdings. WPG Advisers and Root Financial Partners also increased stakes. Biogen reported quarterly earnings per share of $3.60, above the $2.94 consensus. Multiple analysts raised price targets and maintained buy calls.